THE WOODLANDS, Texas, Oct. 31 /PRNewswire/ -- Lexicon Genetics Incorporated (Nasdaq: LEXG) announced today that its presentations at the CIBC World Markets 12th Annual Health Care Conference and the NYSSA Life Sciences Conference will be webcast live.

Lexicons presentation at the CIBC Health Care Conference may be accessed at . Arthur T. Sands, M.D., Ph.D., President and Chief Executive Officer of Lexicon, will present at 10 a.m. (Eastern Time) on Tuesday, November 6th, from The Plaza Hotel in New York City.

In addition, Lexicons presentation at the NYSSA Life Sciences Conference may be accessed at . Alan J. Main, Ph.D., Senior Vice President of Lexicon Pharmaceuticals, will present at 4:10 p.m. (Eastern Time) on Friday, November 9th, from The Chemists Club in New York City.

Following the webcasts, an archived version of both presentations will be available through November 12th, on Lexicons corporate website under the "Investor Relations" tab.

Lexicon Genetics Incorporated is a drug discovery company of the post- genome era, using gene knockout technology to define the functions of genes for the discovery of pharmaceutical products. Lexicon is using this technology to fuel drug discovery programs in cancer, cardiovascular disease, immune disorders, neurological disease, diabetes and obesity. Lexicon has established drug discovery alliances and functional genomics collaborations with leading pharmaceutical and biotechnology companies, research institutes and academic institutions throughout the world to commercialize its technology and further develop its discoveries. Additional information about the Company is available through Lexicons corporate website, .

This press release contains "forward-looking statements," including statements about Lexicons growth and future operating results, discovery and development of products, strategic alliances, and intellectual property, as well as other matters that are not historical facts or information. These forward-looking statements are based on managements current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicons ability to achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, that may cause Lexicons actual results to be materially different from any future results expressed or implied by such forward-looking statements. Information identifying such important factors is contained under "Factors Affecting Forward-Looking Statements" and "Business - Risk Factors" in Lexicons annual report on Form 10-K for the year ended December 31, 2000, as filed with the Securities and Exchange Commission. Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.